Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples